Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Evidence Suggesting the End of Universal Domestic Asbestos Exposure in Metsovo, NW Greece.

Gogali A, Ntzani EE, Manda-Stachouli C, Peristeri S, Tzarouchi L, Laiou E, Konstantinidis A, Constantopoulos SH, Dalavanga Y.

Respiration. 2017;94(6):510-517. doi: 10.1159/000480151. Epub 2017 Oct 12.

PMID:
29020669
2.

Malignant mesothelioma in Metsovo, Greece, from domestic use of asbestos: 30 years later.

Gogali A, Manda-Stachouli C, Ntzani EE, Matthaiou M, Konstantinidis AK, Zampira I, Koubaniou C, Dalavanga Y, Stefanou D, Constantopoulos SH, Daskalopoulos G.

Eur Respir J. 2012 Jan;39(1):217-9. doi: 10.1183/09031936.00017011. No abstract available.

3.

Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers.

Gogali A, Charalabopoulos K, Zampira I, Konstantinidis AK, Tachmazoglou F, Daskalopoulos G, Constantopoulos SH, Dalavanga Y.

Chest. 2010 Nov;138(5):1173-9. doi: 10.1378/chest.10-0157. Epub 2010 May 21.

PMID:
20495107
4.

Proteome analysis of bronchoalveolar lavage in individuals from Metsovo, nonoccupationally exposed to asbestos.

Archimandriti DT, Dalavanga YA, Cianti R, Bianchi L, Manda-Stachouli C, Armini A, Koukkou AI, Rottoli P, Constantopoulos SH, Bini L.

J Proteome Res. 2009 Feb;8(2):860-9. doi: 10.1021/pr800370n.

PMID:
19105609
5.

Prognostic impact of lymphangiogenesis and lymphatic invasion (CD105 expression) in small cell lung carcinoma.

Hardavella G, Arkoumani E, Dalavanga Y, Galanis P, Agnantis NJ, Constantopoulos S, Stefanou D.

Anticancer Res. 2008 Jan-Feb;28(1A):343-7.

6.

Immunohistochemical expression patterns of neural and neuroendocrine markers, the neural growth factor receptors and the beta-tubulin II and IV isotypes in human thymus.

Bai M, Papoudou-Bai A, Karatzias G, Doukas M, Goussia A, Stefanaki K, Rontogianni D, Dalavanga Y, Agnantis NJ, Kanavaros P.

Anticancer Res. 2008 Jan-Feb;28(1A):295-303.

7.

Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis.

Ye Q, Dalavanga Y, Poulakis N, Sixt SU, Guzman J, Costabel U.

Eur Respir J. 2008 May;31(5):1030-6. doi: 10.1183/09031936.00125407. Epub 2008 Jan 23.

8.

Lymphocytic alveolitis: A surprising index of poor prognosis in patients with primary Sjogren's syndrome.

Dalavanga YA, Voulgari PV, Georgiadis AN, Leontaridi C, Katsenos S, Vassiliou M, Drosos AA, Constantopoulos SH.

Rheumatol Int. 2006 Jul;26(9):799-804. Epub 2005 Dec 13.

PMID:
16344933
9.

Decreasing prevalence of pleural calcifications among Metsovites with nonoccupational asbestos exposure.

Manda-Stachouli C, Dalavanga Y, Daskalopoulos G, Leontaridi C, Vassiliou M, Constantopoulos SH.

Chest. 2004 Aug;126(2):617-21.

PMID:
15302752
10.

Gastrointestinal hormones and short-term nutritional schedules in critically ill patients.

Mandragos C, Moukas M, Amygdalou A, Schulpis K, Dalavanga YA, Behrakis PK, Vassiliou MP.

Hepatogastroenterology. 2003 Sep-Oct;50(53):1442-5.

PMID:
14571758
11.

Volume and flow dependence of respiratory mechanics in mechanically ventilated COPD patients.

Vassiliou MP, Amygdalou A, Psarakis CJ, Dalavanga Y, Vassiliou PM, Mandragos KE, Constantopoulos SH, Behrakis PK.

Respir Physiol Neurobiol. 2003 Apr 15;135(1):87-96.

PMID:
12706068
12.

Evaluation of the end-expiratory pressure by multiple linear regression and Fourier analysis in humans.

Mygdalou A, Psarakis C, Vassiliou P, Dalavanga YA, Mandragos C, Constantopoulos SH, Behrakis PK, Vassiliou MP.

Respir Med. 2002 Jul;96(7):499-505. Erratum in: Respir Med 2002 Oct;96(10):847. Amygdalou A [corrected to Mygdalou A].

PMID:
12194633
13.

Additional proteins in BAL fluid of Metsovites environmentally exposed to asbestos: more evidence of "protection" against neoplasia?

Galani V, Constantopoulos S, Manda-Stachouli C, Frangou-Lazaridis M, Mavridis A, Vassiliou M, Dalavanga Y.

Chest. 2002 Jan;121(1):273-8.

PMID:
11796462
14.

Lymphocytic alveolitis and pleural calcifications in nonoccupational asbestos exposure. Protection against neoplasia?

Constantopoulos SH, Dalavanga YA, Sakellariou K, Goudevenos J, Kotoulas OB.

Am Rev Respir Dis. 1992 Dec;146(6):1565-70.

PMID:
1456576
15.

Liquid phase characteristics of bronchoalveolar lavage in primary Sjögren's syndrome.

Dalavanga YA, Constantopoulos SH, Zerva LB, Trekli MM, Kotoulas OO, Moutsopoulos HM.

Chest. 1992 Dec;102(6):1805-7.

PMID:
1446492
16.

Alveolitis correlates with clinical pulmonary involvement in primary Sjögren's syndrome.

Dalavanga YA, Constantopoulos SH, Galanopoulou V, Zerva L, Moutsopoulos HM.

Chest. 1991 Jun;99(6):1394-7.

PMID:
2036821
17.
18.

HLA-DR expression by labial minor salivary gland tissues in Sjögren's syndrome.

Moutsopoulos HM, Hooks JJ, Chan CC, Dalavanga YA, Skopouli FN, Detrick B.

Ann Rheum Dis. 1986 Aug;45(8):677-83.

19.

Labial salivary gland immunopathology in Sjögren's syndrome.

Dalavanga YA, Drosos AA, Moutsopoulos HM.

Scand J Rheumatol Suppl. 1986;61:67-70.

PMID:
3473652
20.

Subclinical manifestations of autoimmune rheumatic diseases in primary Raynaud's phenomenon.

Tzioufas AG, Dalavanga YA, Constantopoulos SH, Tsianos EB, Papadimitriou C, Moutsopoulos HM.

Clin Exp Rheumatol. 1985 Jul-Sep;3(3):243-7.

PMID:
3876901
21.

Respiratory involvement in autoimmune rheumatic diseases is frequent and easy to detect.

Constantopoulos SH, Acritidis NK, Dalavanga YA, Moutsopoulos HM.

Clin Exp Rheumatol. 1983 Jul-Sep;1(3):233-6.

PMID:
6335857

Supplemental Content

Loading ...
Support Center